Related by context. All words. (Click for frequent words.) 78 PRN FDA Approves 78 Meets Primary Endpoint 77 refractory chronic lymphocytic 77 Known hypersensitivity 77 Mg Uk 77 Pegloticase 76 Amgen Neulasta R 76 Soriatane 76 Pivotal Phase III 76 STELARA TM 76 thalidomide Thalomid 76 Peginterferon alfa 2b 76 interferon gamma 1b 76 Achieves Primary Endpoint 76 Zorbtive TM 76 Phase IIb Trial 76 Hormone Refractory Prostate Cancer 75 Completes Patient Enrollment 75 TO AVOID PREGNANCY WHILE 75 adalimumab Humira 75 Mg Usa 75 forodesine 75 Dasatinib 75 relapsed MM 75 alfa 2a 75 ® lenalidomide 75 Severe Sepsis 75 oral prodrug 75 CYP#A# substrate 75 Aflibercept 75 Ziprasidone 75 dasatinib Sprycel ® 75 R sorafenib tablets 75 Adjuvant Treatment 75 Complicated Skin 75 ORENCIA ® 75 Alpha interferons including 75 Interferon beta 1a 75 5 FU leucovorin 75 Fludara ® 75 cetuximab Erbitux R 75 vapreotide acetate 75 MAGE A3 ASCI 75 PEGINTRON TM 75 Xeloda ® 75 Cimzia TM 74 Posaconazole 74 AVASTIN 74 Clolar ® 74 BARACLUDE ® 74 Bosutinib 74 alpha interferons 74 Hsp# Inhibitor 74 sapropterin dihydrochloride 74 sitaxsentan 74 Phase 2b Clinical Trial 74 sorafenib tablets 74 ® bortezomib 74 Temsirolimus 74 oropharyngeal candidiasis OPC 74 Copegus ribavirin 74 dasatinib Sprycel 74 Pemetrexed 74 PEGylated Fab fragment 74 Pivotal Phase 74 paroxetine sertraline 74 Treatment Naïve 74 FDA APPROVES 74 ZOLINZA 74 alefacept 74 Initiate Clinical Trial 74 FUSILEV enhances 74 Romiplostim 74 Paraplatin ® 74 R Saizen R 74 Xcytrin R 74 BARACLUDE R 74 Drug Candidate 74 Initiates Enrollment 74 Tasigna nilotinib 74 Nilotinib 74 Investigational Compound 74 selective modulator 74 Pivotal Study 74 ACTEMRA TM 74 Phase 2a Trial 74 FOR FURTHER INFORMATION ABOUT 74 Novel Oral 74 Myelodysplastic Syndrome MDS 74 methylnaltrexone bromide 74 Mylan Receives Approval 74 Initiates Phase II 74 leukotriene receptor antagonist 74 ergot derivatives 73 Amgen Neulasta ® 73 Genentech Rituxan 73 NDA Submission 73 Vaprisol 73 Gemzar ® 73 virus HCV protease inhibitor 73 brand ciclesonide HFA 73 dextromethorphan quinidine 73 Investigational Treatment 73 ORENCIA R 73 cisplatin gemcitabine 73 topical gel formulation 73 Demonstrates Positive 73 R lenalidomide 73 refractory gout 73 RAPTIVA 73 acyclovir Lauriad R 73 antibody MAb 73 Lamotrigine 73 Navelbine ® 73 biologic DMARD 73 Phase 2b Trial 73 Quinamed 73 etanercept Enbrel 73 Neulasta R 73 Combination REOLYSIN R 73 hypereosinophilic syndrome 73 evaluating tivozanib 73 COPEGUS R 73 Fluticasone 73 Orally administered 73 Safinamide 73 LymphoStat B TM 73 erlotinib Tarceva ® 73 Peginterferon Alfa 2a 73 Patients Treated With 73 Advanced Melanoma 73 Certolizumab 73 Tarceva TM 73 Files IND 73 lenalidomide Revlimid R 73 SinuNase TM 73 metastatic malignant 73 Antitumor Activity 73 Fludarabine 73 induced macular edema 73 Submits NDA 73 Initiate Phase 73 Fast Track Status 73 orally administered inhibitor 73 beta 1a 73 Newly Diagnosed Multiple Myeloma 73 LymphoStat B belimumab 73 Begins Dosing 73 humanized interleukin 6 73 Investigational Oral 73 PEGylated anti 73 FEMALES SHOULD BE ADVISED 73 Pegylated Interferon 73 ribavirin RBV 73 Velcade bortezomib 73 diarrhea predominant irritable 73 mycophenolic acid 73 docetaxel Taxotere ® 73 Personalized Immunotherapy 73 panitumumab Vectibix 73 Receives Orphan Drug Designation 73 Carbamazepine 73 investigational monoclonal antibody 73 IV Busulfex 73 MKC# MT 73 mGluR5 NAM 73 ara C 73 Vidaza ® 73 Pafuramidine 73 non nucleoside inhibitor 73 Bicalutamide 73 Sprycel dasatinib 72 Glatiramer Acetate 72 Noxafil 72 aripiprazole Abilify 72 gefitinib Iressa 72 paclitaxel Taxol R 72 novel emulsion formulation 72 Refractory Hodgkin Lymphoma 72 Phase III Clinical Trial 72 CIMZIA R 72 Study Evaluating 72 Vicriviroc 72 Levoleucovorin 72 lumiliximab 72 TELINTRA 72 severe hypersensitivity reactions 72 JAK Inhibitor 72 Elotuzumab 72 Announces Tentative Approval 72 Atripla combines 72 Panzem R NCD 72 leukemia AML 72 imatinib Gleevec ® 72 denileukin diftitox 72 myelodysplastic myeloproliferative diseases 72 Monotherapy 72 Cutaneous T 72 elotuzumab 72 Omacetaxine 72 Maribavir 72 Irinotecan 72 post herpetic neuralgia PHN 72 Gleevec imatinib mesylate 72 Fulvestrant 72 formerly LymphoStat B 72 Phase III Trial 72 xanthine oxidase inhibitor 72 Recombinant Human 72 Tezampanel 72 Dementia Related Psychosis 72 FOLFOX6 chemotherapy regimen 72 paclitaxel Taxol ® 72 PDX pralatrexate 72 2 methoxyestradiol 72 cancer neuroendocrine tumor 72 sertraline Zoloft 72 Ecallantide 72 ritonavir boosted 72 divalproex sodium 72 Nebulized 72 Anthracycline 72 TNF Tumor Necrosis Factor 72 pegylated interferons 72 Vildagliptin 72 Panzem R 72 nilotinib Tasigna 72 Platinol ® 72 IMiDs ® 72 systemic anaplastic large 72 PEG IFN 72 generation purine nucleoside 72 Transdermal Patch 72 Vitrasert R 72 novel VDA molecule 72 CYT# potent vascular disrupting 72 acetonide FA 72 Copegus ® 72 8mg/kg 72 itraconazole Sporanox 72 visilizumab 72 Interferon Beta 72 Peginterferon 72 Demonstrates Significant 72 Xelox 72 included exfoliative dermatitis 72 Annamycin 72 Oral Fingolimod 72 CIMZIA ™ 72 Single Dose 72 Expanded Indication 72 pioglitazone HCl 72 Medoxomil 72 plus COPEGUS 72 NEUPOGEN 72 Ozarelix 72 R adefovir dipivoxil 72 Pegylated Liposomal Doxorubicin 72 induce orthostatic hypotension 72 rasagiline tablets 72 TYGACIL 72 Prolongs Survival 72 Trial Evaluating 72 sitagliptin metformin 72 mitoxantrone plus 72 Pazopanib 72 Capecitabine 72 Ixempra 72 interferon beta 1a infertility 72 ONTAK 72 administered concomitantly 72 Vidaza azacitidine 72 Gleevec Glivec 72 FASLODEX 72 Previously Treated 72 Initiates Clinical Trial 72 Presents Preclinical Data 72 Initiates Clinical 72 PENTASA 72 corticotropin injection 72 BUPHENYL 72 galiximab 72 Inhalation Aerosol 72 Actimmune ® 72 dasatinib 72 Hycamtin ® 72 Parnate 72 Degarelix 72 VIVITROL ® 72 hoFH 72 DOXIL 72 peginterferon alfa 72 anthracycline taxane 72 Betaferon R 72 Lupus Nephritis 72 Rhinocort 72 Immunotherapeutic 72 Pegasys ® 71 levocetirizine 71 Azacitidine 71 vinorelbine tartrate 71 GW# [003] 71 CIMZIA TM 71 Receives Positive Opinion 71 REVLIMID ® 71 Aptivus ® 71 Mycophenolate Mofetil 71 quetiapine Seroquel 71 IND Application 71 Raptiva R 71 oncolytic virus therapies 71 Launches Generic Version 71 Phase IIb Clinical Trial 71 herpetic keratitis 71 Natalizumab 71 Luteinizing Hormone Releasing Hormone 71 Sustiva efavirenz 71 AZT zidovudine Retrovir 71 BENLYSTA ® 71 PEGASYS ® 71 chronic eosinophilic leukemia 71 REVLIMID R 71 PNP inhibitor 71 Kepivance 71 histamine dihydrochloride 71 Glufosfamide 71 INVANZ 71 Generic Version 71 MEK Inhibitor 71 abacavir lamivudine 71 CAELYX 71 Vidaza R 71 CTAP# Capsules 71 pan histone deacetylase 71 Effexor venlafaxine 71 R bisoprolol Euthyrox 71 EFFEXOR XR 71 lamotrigine Lamictal 71 liposomal formulation 71 Darinaparsin 71 Granted Orphan Drug 71 alkylating agent 71 Heterozygous Familial Hypercholesterolemia 71 See CLINICAL PHARMACOLOGY 71 IMiDs ® compound 71 Inhalation Solution 71 efalizumab 71 MGd 71 SUPPRELIN R LA 71 receptor tyrosine kinase inhibitor 71 Epratuzumab 71 FOLOTYN ® 71 Kuvan R 71 demonstrated antitumor activity 71 desvenlafaxine succinate 71 Phase 2b Study 71 candidates Azedra TM 71 APTIVUS r 71 5 Fluorouracil 71 Tyrosine Kinase Inhibitor 71 Improves Outcomes 71 trastuzumab Herceptin R 71 Pegylated interferon 71 Neulasta ® 71 5 fluorouracil leucovorin 71 ARCALYST ® 71 Pegasys peginterferon alfa 2a 71 JAK2 Inhibitor 71 Archexin 71 R rilonacept Injection 71 Bazedoxifene 71 arsenic trioxide injection 71 YONDELIS 71 headache abdominal pain 71 Evoltra ® 71 Vfend 71 Interferon beta 1b 71 Randomized Phase 71 Nipent R 71 MOVIPREP R 71 Leukine ® 71 Receives Approvable Letter 71 pan HDAC inhibitor 71 HCl capsules 71 Interferon Alpha 71 Alkeran 71 Dacogen injection 71 certolizumab 71 Flu Cy 71 canakinumab 71 achieved CCyR 71 oxaliplatin Eloxatin 71 docetaxel Taxotere R 71 receiving INTRON 71 Shows Efficacy 71 metformin HCl 71 Danazol 71 R abatacept 71 ® decitabine 71 Paliperidone Palmitate 71 CIMZIA TM certolizumab pegol 71 plus DOXIL 71 Submits Biologics License Application 71 Certolizumab pegol 71 Efficacy Trial 71 cromolyn sodium 71 Raptiva ® 71 Gel repository corticotropin injection 71 Relapsed Refractory 71 REYATAZ R 71 metaglidasen 71 R memantine HCl 71 pegylated interferon alpha 71 dual endothelin receptor antagonist 71 Moxifloxacin 71 Patients Receiving 71 trimethoprim sulfamethoxazole 71 interferon alfacon 1 71 Cleviprex TM clevidipine 71 ceftazidime 71 Aeolus Pharmaceuticals Announces 71 Adjunctive Therapy 71 ALN HPN 71 plus prednisone prednisolone 71 R metformin Concor 71 Toremifene 71 treat chronic sinusitis 71 non metastatic osteosarcoma 71 CYP#A# CYP#D# 71 telomerase therapeutic 71 Eszopiclone 71 fluvoxamine maleate 71 Erlotinib 71 ULORIC 71 cyclophosphamide methotrexate 71 Acetate Rectal Suppositories 71 buccal tablets 71 non splenectomized 71 potentially hepatotoxic 71 FDA Approvals 71 BUPHENYL R 71 Pooled Analysis 71 Teva Provides Update 71 AVONEX ® 71 tigecycline 71 memantine HCl 71 rilonacept 71 bortezomib Velcade 71 5 lipoxygenase inhibitor 71 tiuxetan 71 AMEVIVE 71 sorafenib Nexavar 71 miconazole Lauriad ® 71 REBETOL combination therapy 71 Granulocyte Colony Stimulating Factor 71 bevacizumab Avastin R 71 BCG refractory carcinoma 71 Tigecycline 71 erlotinib Tarceva R 71 ribavirin USP 71 Desvenlafaxine Succinate 71 Daptomycin 71 Acute Attacks 71 FDA Accepts 70 Demonstrates Potential 70 LEVAQUIN ® 70 Targretin capsules 70 Oral Calcitonin 70 intranasal formulation 70 anthracyclines taxanes 70 tazobactam 70 Clinical Trial Results 70 Metastatic Colorectal Cancer 70 Monopril 70 Eraxis 70 nilotinib Tasigna ® 70 Abrupt discontinuation 70 Plaque Psoriasis 70 Naive Patients 70 Ganciclovir 70 4mg/kg 70 Bosentan 70 Peginterferon alfa 2a 70 Presents Positive 70 nitrofurantoin 70 Pegylated 70 reslizumab 70 G#DT 70 Atypical Hemolytic Uremic Syndrome 70 Fondaparinux 70 salmeterol fluticasone 70 Cimzia ® certolizumab pegol 70 R bendamustine hydrochloride 70 PKC# 70 ONCASPAR 70 Kamada AAT 70 metastatic GIST 70 haematologic 70 RoACTEMRA 70 XAGRID 70 GABITRIL 70 hyperphenylalaninemia HPA due 70 nilotinib 70 prokinetic agent 70 Plicera 70 Peg IFN 70 gets USFDA nod 70 P#X# antagonist 70 cetuximab Erbitux ® 70 sunitinib Sutent 70 PRISTIQ 70 guanfacine extended release 70 SUSTENNA TM 70 somatostatin analog 70 Paliperidone ER 70 INFERGEN 70 REMINYL ® 70 ARCALYST 70 AGILECT R 70 comparator arm 70 Ramelteon 70 basiliximab 70 interferon ribavirin 70 Telbivudine 70 Adalimumab 70 evaluating satraplatin 70 Fluconazole 70 sunitinib Sutent ® 70 rabeprazole 70 terlipressin 70 acitretin 70 ALVESCO ® 70 Initiates Phase III 70 vidofludimus 70 Crofelemer budesonide foam 70 tenofovir emtricitabine 70 receiving prophylactic anticoagulation 70 CANCIDAS 70 Keppra XR 70 cardiometabolic diseases Glucophage 70 mesylate 70 ® adefovir dipivoxil 70 Chronic Hepatitis C 70 PROVENGE ® 70 primidone 70 Cardiotoxicity 70 UPLYSO 70 Dapagliflozin 70 ISTODAX ® 70 Telithromycin 70 DEB# 70 antiepileptics 70 Azilect ® 70 GOUT 70 Improves Survival 70 Ph + acute lymphoblastic 70 risedronate sodium tablets 70 Infusion Reactions Severe 70 pregabalin Lyrica 70 Phase IIa Clinical Trial 70 Brentuximab Vedotin SGN 70 bevacizumab Avastin ® 70 COLAZAL R 70 Lubiprostone 70 AAG geldanamycin analog 70 therapeutically inactive prodrug 70 abacavir sulfate lamivudine 70 bleeding pallor 70 Follicular Lymphoma 70 oral dual endothelin 70 Warfarin Coumadin 70 XL# anticancer compounds 70 ANDA Filing 70 Taxotere ® 70 Relapsing Remitting Multiple Sclerosis 70 PI3K/Akt pathway inhibitor 70 HP Acthar Gel repository 70 ritonavir boosted atazanavir 70 efavirenz EFV 70 oral rivaroxaban 70 Is Well Tolerated 70 metformin accumulation 70 investigational humanized monoclonal antibody 70 oxypurinol 70 Hepatotoxicity 70 metastatic castration resistant 70 Rebif ® 70 Pharmacokinetics PK 70 Previously Untreated 70 GVAX ® 70 Sanofi Pasteur Fluzone 70 metastatic neuroendocrine tumors 70 lintuzumab SGN 70 monoclonal antibody IgG1 Mab 70 lexidronam injection 70 metastatic hormone refractory 70 receiving XGEVA 70 insulin glulisine 70 Thalomid ® 70 Interferon beta 70 2A receptor agonist 70 Proquin XR 70 Topotecan 70 Humanized Anti 70 Pulmonary Arterial Hypertension 70 Ovitrelle R Serostim 70 VFEND 70 Successfully Completes Phase 70 Silodosin 70 Emtriva Viread 70 Albuferon TM 70 Epidermal Growth Factor Receptor 70 goserelin 70 recurrent glioblastoma multiforme 70 THALOMID 70 NICE Recommends 70 Azathioprine 70 Teriflunomide 70 highly purified pasteurized 70 Myelofibrosis 70 haloperidol Haldol 70 Angiotensin Converting Enzyme 70 dihydrochloride 70 Pegintron 70 nucleotide analogue 70 temsirolimus Torisel ® 70 Helicobacter pylori eradication 70 eosinophilic asthma 70 Navelbine 70 MYLOTARG 70 TRANSDUR ® 70 neutropenia dehydration dyspnea 70 baminercept 70 Calcium Acetate 70 Orally Disintegrating Tablets 70 VELCADE melphalan 70 voriconazole 70 Elagolix 70 cell lymphoma CTCL 70 Dalbavancin 70 Gleevec resistant 70 estramustine 70 venlafaxine Effexor 70 Demonstrated Significant 70 MetroGel 70 Cytarabine 70 diclofenac Voltaren 70 POSIDUR TM 70 sargramostim 70 Traficet EN 70 ABILIFY ® 70 Tofranil 70 Elitek 70 Kinoid 70 FDA Okays 70 TBC# 70 #mg/#mg 70 PROCRIT ® 70 CTAP# 70 octreotide acetate 70 alvespimycin 70 Folfox 70 adenosine injection 70 naïve HCV 70 R# #mg BID 70 mertansine 70 Neupro R 70 serotonin norepinephrine reuptake inhibitor 70 Intravitreal 70 LEUKINE 70 prescribed proton pump 70 Virologic 70 complement inhibitor eculizumab 70 Catena ® 70 Prilosec omeprazole 70 MyVax R 70 Telintra 70 Ribavirin causes 70 Submits Supplemental 70 azilsartan medoxomil 70 tenofovir disoproxil fumarate Viread 70 lucinactant 70 OMNARIS HFA 70 Perforomist ™ Inhalation Solution 70 Methylnaltrexone 70 angiotensin converting enzyme inhibitor 70 HuMax EGFr 70 TMP SMX 70 Novantrone 70 LOVENOX R 70 Oral Formulation 70 Ropinirole 70 hyperplasia BPH 70 Relapsing Multiple Sclerosis 70 IXEMPRA 70 TELINTRA R 70 FS Antihemophilic Factor Recombinant 70 INSPIRE Trial Phase III 70 Pruvel TM 70 Ambrisentan 70 interferon alfa 2b 70 Etanercept 70 Kit CD# positive 70 delivers fluocinolone acetonide FA 70 ALVESCO R 70 TNF Blockers 70 alpha 2a 70 orally inhaled 70 epoetin alpha 70 Nexavar ® 70 5 HT3 antagonist 69 Treated Patients 69 Shows Statistically Significant 69 inhalation aerosol 69 Psoriasis Drug 69 alfa 2b 69 Amrubicin 69 Ciclesonide 69 tinidazole 69 pancreatic enzyme replacement 69 Platinol ® cisplatin 69 Troxatyl 69 Serostim ® 69 GENERIC SILDENAFIL SOFT Generic 69 Androxal TM 69 Clofarabine 69 FOLFOX6 69 piperacillin tazobactam 69 mapatumumab 69 Trastuzumab Herceptin 69 evaluating picoplatin 69 Oxaliplatin 69 HDAC Inhibitor 69 HuMax 69 tazarotene 69 IMiDs 69 doxercalciferol 69 pentostatin 69 Namenda ® 69 Immunosuppressant 69 catheter occlusion 69 Saquinavir 69 Remicade infliximab 69 Long Term Efficacy 69 esomeprazole Nexium 69 dexamethasone Decadron 69 BUPHENYL R sodium phenylbutyrate 69 combines bupropion 69 inflammatory PDE 69 Well Tolerated 69 AVAPRO 69 oral nucleoside analogue 69 humanised monoclonal antibody 69 fludarabine phosphate 69 Eltrombopag 69 Vitrasert ® 69 PROCTOCORT R 69 pomalidomide 69 Treatment Experienced 69 Lenalidomide 69 GlaxoSmithKline Requip 69 Benign Prostatic Hyperplasia 69 Oracea TM 69 temsirolimus Torisel 69 Clindamycin 69 toenail onychomycosis 69 lansoprazole Prevacid 69 Loceryl ® 69 TYKERB 69 amifostine 69 tumor lysis syndrome 69 HGS ETR1 mapatumumab 69 irinotecan containing 69 DOXIL R 69 dopamine partial agonist 69 nicardipine 69 Dexilant 69 advanced metastatic renal 69 pegylated liposomal doxorubicin 69 Dapoxetine 69 bone marrow reticulin deposition 69 icatibant 69 Genasense ® oblimersen 69 atypical Hemolytic Uremic Syndrome 69 Maleate 69 RISPERDAL 69 Femara letrozole 69 sitagliptin Januvia 69 Demonstrate Significant 69 verteporfin 69 Mirapexin 69 corticosteroid dexamethasone 69 Piperacillin 69 Abbott HUMIRA 69 Taxotere chemotherapy 69 budesonide foam 69 EGFR tyrosine kinase inhibitor 69 Metastatic Melanoma 69 Completes Enrollment 69 Sudhir Agrawal D.Phil 69 Aryplase 69 Chronic Hepatitis B 69 LibiGel ® 69 Xanafide 69 refractory cutaneous T 69 budesonide inhalation suspension 69 angioneurotic edema 69 abacavir Ziagen 69 Fibrillex TM 69 #mg Tablets [002] 69 invasive candidiasis 69 Fungal Infections 69 HIV treatments Reyataz 69 Gout Drug 69 levetiracetam Keppra 69 Significantly Improved 69 Decitabine 69 adefovir dipivoxil 69 pemetrexed Alimta 69 Carbidopa 69 leukemia CLL 69 phase IIb trial 69 INTEGRILIN ® 69 Simulect 69 RLAI 69 pegfilgrastim 69 RANK Ligand inhibitor 69 Fludara 69 uric acid lowering 69 SNT-MC#/idebenone 69 Generalized Anxiety Disorder 69 TRISENOX ® 69 peginterferon alfa 2b 69 Solazed TM 69 RezularTM 69 pseudobulbar affect PBA 69 hormone LHRH antagonist 69 Solaraze 69 PANVAC VF 69 SIMPONI ® 69 Phase IIa Trial 69 NS5B polymerase 69 Significantly Improves 69 PEG interferon 69 HCl Tablets 69 Octreotide 69 Demonstrates Potent 69 Advanced Renal Cell 69 plus dexamethasone 69 clodronate 69 Sanofi Aventis Taxotere 69 Presents Preclinical 69 recurrent metastatic ovarian cancer 69 Patient Enrollment 69 Navelbine R 69 oral picoplatin 69 Cimzia certolizumab pegol 69 Tolvaptan 69 Receives Orphan Drug 69 Actonel risedronate 69 relapsing remitting MS RRMS 69 selective phosphodiesterase 69 Aurora Kinase 69 paroxetine Paxil 69 Abatacept 69 Supplemental Biologics License Application 69 Paxil paroxetine 69 KETEK 69 systemic juvenile idiopathic 69 cidofovir 69 Budesonide 69 Sitagliptin 69 Triapine 69 ALN PCS 69 rituximab Rituxan 69 Desvenlafaxine 69 TLK# 69 Filgrastim 69 oral beclomethasone dipropionate 69 FUSILEV ® 69 Cancidas 69 Camptosar ® 69 Hepatitis C Genotype 69 Serious adverse reactions 69 EMSAM 69 tolterodine ER 69 1mg 2mg 69 Bendamustine 69 Tacrolimus 69 LAB CGRP 69 Omalizumab 69 Carbidopa Levodopa 69 PEG SN# 69 brivaracetam 69 erlotinib Tarceva 69 Soft Tissue Sarcoma 69 Vaccine Adjuvant 69 Protease Inhibitor 69 balsalazide tablet 69 follicular lymphoma FL 69 antiplatelet medications 69 AGILECT ® 69 Relapsed Multiple Myeloma 69 Vimpat R 69 ARIXTRA R 69 KAPIDEX 69 Crixivan 69 gastrointestinal stromal tumors GIST 69 anagrelide 69 adriamycin 69 SUTENT ® 69 Hydrochlorothiazide Tablets 69 acute mania 69 MEVACOR 69 Fluorouracil 69 INTEGRILIN R eptifibatide Injection 69 Phase III Clinical Trials 69 HER2 Positive Breast Cancer 69 nucleoside analog 69 #I TM# 69 Temodar ® 69 plus prednisone 69 Allergic Rhinitis 69 EGFR TKI 69 proprietary intravenous formulation 69 VAPRISOL 69 Plus Ribavirin 69 Myeloma Patients 69 velafermin 69 VISICOL R 69 Zoloft sertraline 69 myopathy rhabdomyolysis 69 developing Bicifadine serotonin 69 Shows Promise Against 69 Ovidrel 69 Oral Spray 69 MabThera Rituxan 69 peginterferon alfa 2a Pegasys 69 Long acting beta2 69 Capsules CII 69 FDA Approvable Letter 69 indinavir Crixivan 69 Nexavar sorafenib 69 Rilonacept 69 cutaneous T 69 MAXALT 69 investigational pharmacologically unique 69 Prophylactic Treatment 69 Carvedilol 69 aflibercept VEGF Trap 69 prescription laxative 69 capecitabine Xeloda 69 Romidepsin 69 PEGylated interferon beta 1a 69 polyglutamate 69 Vandetanib 69 Sapacitabine 69 Gastrointestinal Stromal Tumors 69 Double Blind Randomized 69 Relapsed Refractory Multiple Myeloma 69 STELARA ® 69 Demonstrates Efficacy 69 alpha 2b 69 Pivotal Trial 69 Improved Survival 69 Submits Response 69 Oxybutynin 69 Sycrest 69 Phase 2a Clinical Trial 69 serum phosphorous 69 zoledronate 69 bisoprolol 69 alfuzosin 69 secondary hyperparathyroidism 69 Montelukast 69 Cholesterol Lowering Drug 69 overactive bladder syndrome 69 somatropin Kuvan R 69 huC# DM4 69 oral methylnaltrexone 69 R Bortezomib 69 EDEMA3 69 quetiapine fumarate 69 imatinib Gleevec 69 immunosuppressant drug 69 gemcitabine Gemzar 69 cediranib 69 potent CYP#A# inhibitors 69 fluvastatin 69 Tekamlo 69 Serostim R 69 valsartan amlodipine 69 docetaxel chemotherapy 69 SinuNase ™ 69 NOXAFIL 69 oral antidiabetic medication 69 hypertrichosis occurred 69 Aztreonam Lysine 69 Levaquin levofloxacin